Ross R Reichard
Overview
Explore the profile of Ross R Reichard including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
167
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ghatamaneni S, Hruska C, Shin I, Bruinsma T, Scott N, Lee J, et al.
Acta Neuropathol
. 2025 Mar;
149(1):26.
PMID: 40085238
Recent developments in tau positron emission tomography (PET) radiotracers have enhanced the visualization of tau aggregates in Alzheimer's disease (AD). The maturity level of neurofibrillary tangles can affect its recognition...
2.
Ferreira D, Przybelski S, Lesnick T, Diaz-Galvan P, Schwarz C, Murray M, et al.
JAMA Neurol
. 2025 Jan;
82(3):285-294.
PMID: 39804619
Importance: Although 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) is a well-established cross-sectional biomarker of brain metabolism in dementia with Lewy bodies (DLB), the longitudinal change in FDG-PET has not been characterized....
3.
Lee J, Burkett B, Min H, Senjem M, Dicks E, Corriveau-Lecavalier N, et al.
Brain
. 2023 Oct;
147(3):980-995.
PMID: 37804318
Given the prevalence of dementia and the development of pathology-specific disease-modifying therapies, high-value biomarker strategies to inform medical decision-making are critical. In vivo tau-PET is an ideal target as a...
4.
Buciuc M, Koga S, Pham N, Duffy J, Knopman D, Ali F, et al.
Eur J Neurol
. 2022 Oct;
30(2):321-333.
PMID: 36256511
Background: Globular glial tauopathy (GGT) has been associated with frontotemporal dementia syndromes; little is known about the clinical and imaging characteristics of GGT and how they differ from other non-globular...
5.
Josephs K, Tosakulwong N, Gatto R, Weigand S, Ali F, Botha H, et al.
Ann Neurol
. 2022 Sep;
92(6):1016-1029.
PMID: 36054427
Objective: This study was undertaken to assess cross-sectional and longitudinal [ F]-flortaucipir positron emission tomography (PET) uptake in pathologically confirmed frontotemporal lobar degeneration (FTLD) and to compare FTLD to cases...
6.
Josephs K, Duffy J, Clark H, Utianski R, Strand E, Machulda M, et al.
Nat Commun
. 2021 Jun;
12(1):3452.
PMID: 34103532
Progressive apraxia of speech is a neurodegenerative syndrome affecting spoken communication. Molecular pathology, biochemistry, genetics, and longitudinal imaging were investigated in 32 autopsy-confirmed patients with progressive apraxia of speech who...
7.
Townley R, Graff-Radford J, Mantyh W, Botha H, Polsinelli A, Przybelski S, et al.
Brain Commun
. 2020 Jul;
2(1):fcaa068.
PMID: 32671341
We report a group of patients presenting with a progressive dementia syndrome characterized by predominant dysfunction in core executive functions, relatively young age of onset and positive biomarkers for Alzheimer's...
8.
Choudhury P, Scharf E, Paolini 2nd M, Graff-Radford J, Alden E, Machulda M, et al.
J Neurol
. 2020 May;
267(9):2697-2704.
PMID: 32440921
Background: Pick's disease (PiD) is a unique subtype of frontotemporal lobar degeneration characterized pathologically by aggregates of 3-Repeat tau. Few studies have examined the clinical variability and disease progression in...
9.
Zeydan B, Lowe V, Reichard R, Przybelski S, Lesnick T, Schwarz C, et al.
Ann Neurol
. 2020 Jan;
87(4):556-567.
PMID: 31970802
Objective: To investigate β-amyloid and tau depositions using Pittsburgh compound B (PiB) positron emission tomography (PET) and AV1451 tau PET imaging in aging multiple sclerosis (MS) patients. Methods: Patients with...
10.
Langman L, Jannetto P, Reichard R
Clin Chem
. 2019 Mar;
65(4):598-599.
PMID: 30923064
No abstract available.